Bausch Health Companies (BHC) Asset Utilization Ratio (2010 - 2026)
Bausch Health Companies (BHC) posted Asset Utilization Ratio of 0.44 for Q2 2026, up 6.34% sequentially from 0.41 in Q1 2026, and up 19.91% YoY from 0.37 in Q2 2025.
Bausch Health Companies (BHC) Asset Utilization Ratio (2010 - 2026) Analysis & Trends
Bausch Health Companies has reported Asset Utilization Ratio for 17 years, with the latest figure at 0.44 in Q2 2026.
- Quarterly Asset Utilization Ratio rose 19.91% year-over-year to 0.44 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.44 (up 19.91% YoY) and the FY2025 annual result came in at 0.39, up 8.64% from the prior year.
- Asset Utilization Ratio rose to 0.44 in Q2 2026 per BHC's latest filing, from 0.41 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.48 in Q3 2022 and troughed at 0.31 in Q4 2022.
- A 5-year average of 0.38 and a median of 0.37 in 2024 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio soared 75.09% in 2022, then sank 32.8% in 2023.
- Over 5 years, Asset Utilization Ratio stood at 0.31 in 2022, then rose by 2.98% to 0.32 in 2023, then increased by 12.71% to 0.36 in 2024, then grew by 6.41% to 0.39 in 2025, then advanced by 14.08% to 0.44 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.44, 0.41, and 0.39 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Bausch Health Companies | 2.57 Bn | 730.75 Mn | 2.10 Bn | 0.44 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.44 |
| Mar 31, 2026 | 0.41 |
| Dec 31, 2025 | 0.39 |
| Sep 30, 2025 | 0.37 |
| Jun 30, 2025 | 0.37 |
| Mar 31, 2025 | 0.37 |
| Dec 31, 2024 | 0.36 |
| Sep 30, 2024 | 0.36 |
| Jun 30, 2024 | 0.34 |
| Mar 31, 2024 | 0.33 |
| Dec 31, 2023 | 0.32 |
| Sep 30, 2023 | 0.32 |
| Jun 30, 2023 | 0.33 |
| Mar 31, 2023 | 0.32 |
| Dec 31, 2022 | 0.31 |
| Sep 30, 2022 | 0.48 |
| Jun 30, 2022 | 0.46 |
| Mar 31, 2022 | 0.46 |
| Dec 31, 2021 | 0.46 |
| Sep 30, 2021 | 0.29 |